ESPERITE (ESP) Q1 consolidated revenue higher compared to budget
EBITDA improved compared to budget as a result of cost control
Zutphen, the Netherlands – 31 May 2017
Genoma grows and widens its footprint on the market.
CryoSave newly configured, launches new products for Q2 2016.
Effectiveness of cost saving programs and optimisation of processes show positive results.
Zutphen, the Netherlands – 28 April 2016
ESPERITE N.V. Trading Update. Q1 confirms strategy and forecasted growth with Genoma
The company is now building the future. CryoSave is on track and Genoma shows its ability to support the current published forecasts and ambitious next developments.
Zutphen, The Netherlands – 19 May 2015
ESPERITE notifies that the date of the Annual General Meeting (“AGM”) has changed and now it will be held on the 17 of June 2015.
The change of date is due to the extended period of time allocated to complete all audit-related procedures with the new audit firm. A subsequent communication will convene the AGM officially and provide all the documentation and pertaining information.
ESPERITE also informs that the Q1 trading update will be released on 19 May 2015.
Geneva, Switzerland – 16 April 2015
Cryo-Save Group N.V. (Euronext: CRYO, ‘Cryo-Save’, or ‘the Group’), the leading International stem cell storage company and the largest family stem cell bank In Europe, announces its trading update for the quarter ended 31 March 2014.
Cryo-Save Group N.V. (Euronext: CRYO, ‘Cryo-Save’, or ‘the Group’), the leading international stem cell storage company and the largest family stem cell bank in Europe, announces its trading update for the quarter ended 31 March 2013.
Cryo-Save Group N.V. (Euronext: CRYO, ‘Cryo-Save’, of ‘de Groep’), het toonaangevende internationale bedrijf voor stamcelopslag en de grootste familiestamcelbank in Europa, publiceert de trading update over het kwartaal eindigend op 31 maart 2013.
Headwind in Southern Europe
Cryo-Save Group N.V. (Euronext: CRYO, ‘Cryo-Save’, or ‘the Group’), the leading international stem cell storage company and the largest family stem cell bank in Europe, announces its trading update for the quarter ended 31 March 2012.
Tegenwind in Zuid-Europa
Cryo-Save Group N.V. (Euronext: CRYO, ‘Cryo-Save’, or ‘the Group’), the leading international stem cell storage company and the largest family stem cell bank in Europe, announces its trading update for the quarter ended 31 March 2012.
Revenue up 8% to €10.4 million and operating profit up 53% to €1.3 million
Cryo-Save Group N.V. (Euronext: CRYO, ‘Cryo-Save’, or ‘the Group’), the leading international family stem cell bank, announces its trading update for the quarter ended 31 March 2011.
